Captopril: Difference between revisions

Revision as of 14:03, 28 March 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2], Ahmed Zaghw, M.D. [3]

For patient information about Captopril, click here.

Synonyms / Brand Names: Capoten

Captopril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.

@@ Line 23: / Line 23: @@
 * [[Captopril and Hydrochlorothiazide tablet]]
-==References==
-* Atkinson AB, Robertson JIS. Captopril in the treatment of hypertension and cardiac failure. Lancet 1979;2(8147):836–9. PMID 90928
-* Patchett AA, Harris E, Tristam EQ, et al. A new class of angiotensin-converting enzyme inhibitors. Nature 1980;288(5788):280–3. PMID 6253826
-* Rossi S, editor. [[Australian Medicines Handbook]] 2006. Adelaide: Australian Medicines Handbook; 2006.
-* Smith CG, Vane JR. The discovery of captopril. FASEB J 2003;17:788-9. [http://www.fasebj.org/cgi/content/full/17/8/788 Fulltext]. PMID 12724335.
-==See also==
-*[[Captopril challenge test]]
-*[[Captopril suppression test]]
 ==External links==